Back to Search Start Over

1O Neratinib + capecitabine vs lapatinib + capecitabine in HER2+ metastatic breast cancer previously treated with ≥2 HER2-directed regimens: Exploratory biomarker analyses from phase III NALA trial.

Details

Language :
English
ISSN :
09237534
Volume :
31
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152683733
Full Text :
https://doi.org/10.1016/j.annonc.2020.03.137